FTC Blasts Androgel Pay-For-Delay Ruling In 11th Circ.
The Federal Trade Commission on Monday urged the Eleventh Circuit to reconsider its ruling that upheld the so-called pay-for-delay deals Solvay Pharmaceuticals Inc. inked to block generic versions of its blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article